01/07/2025
3:15 PM | Huang Jane (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
6:41 AM | Prelude Therapeutics (Issuer)
Vaddi Krishna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
6:49 AM | Combs Andrew (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
6:33 AM | Prelude Therapeutics (Issuer)
Vaddi Krishna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
6:35 AM | Lim Bryant David (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:45 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:27 PM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
6:40 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
8:02 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:20 AM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:10 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for PRLD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/18/2024
3:26 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
5:55 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
11:15 PM | Prelude Therapeutics (Filer)
| Form EFFECT | |
05/08/2024
11:15 PM | Prelude Therapeutics (Filer)
| Form EFFECT | |
05/07/2024
6:12 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:20 AM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
3:24 PM | Prelude Therapeutics (Filer)
| Form S-3/A | |
04/26/2024
3:21 PM | Prelude Therapeutics (Filer)
| Form ARS | |
04/26/2024
3:19 PM | Prelude Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:05 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
4:22 PM | Prelude Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
3:22 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
12:34 PM | Prelude Therapeutics (Subject)
UBS ASSET MANAGEMENT AMERICAS INC (Filed by)
| Form SC 13G/A | |
02/12/2024
4:30 PM | Flynn James E (Filed by)
Prelude Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
3:26 PM | Prelude Therapeutics (Subject)
Vaddi Krishna (Filed by)
| Form SC 13G/A | |
